LGALS8 blocking peptide product blog
Tags: LGALS8 ; Blocking Peptide; LGALS8 blocking peptide;
The LGALS8 lgals8 (Catalog #MBS9223020) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The LGALS8 lgals8 product has the following accession number(s) (GI #292495094) (NCBI Accession #O00214.4) (Uniprot Accession #O00214). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Lectin with a marked preference for 3\'-O-sialylated and 3\'-O-sulfated glycans.
Cellular Location: Cytoplasm. Tissue Location: Ubiquitous. Selective expression by prostate carcinomas versus normal prostate and benign prostatic hypertrophy. Blood, Connective Tissue, Embryonic Tissue, Eye, Kidney, Lung, Muscle, Prostate, Skin, Vascular tissues are correlated with this protein. Adenocarcinoma, Breast Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Cell Transformation, Neoplastic, Inflammation, Kidney Diseases, Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms are some of the diseases may be linked to LGALS8 Antibody (C-term) Blocking Peptide.